Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Receivables (2023 - 2025)

Historic Receivables for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $40.8 million.

  • Baird Medical Investment Holdings' Receivables rose 108640.75% to $40.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $40.8 million, marking a year-over-year increase of 108640.75%. This contributed to the annual value of $46.6 million for FY2024, which is 3564.84% up from last year.
  • According to the latest figures from Q2 2025, Baird Medical Investment Holdings' Receivables is $40.8 million, which was up 108640.75% from $46.6 million recorded in Q4 2024.
  • Baird Medical Investment Holdings' Receivables' 5-year high stood at $46.6 million during Q4 2024, with a 5-year trough of -$4.1 million in Q2 2024.
  • Over the past 3 years, Baird Medical Investment Holdings' median Receivables value was $37.6 million (recorded in 2023), while the average stood at $29.4 million.
  • Its Receivables has fluctuated over the past 5 years, first skyrocketed by 3565.67% in 2024, then skyrocketed by 108640.75% in 2025.
  • Baird Medical Investment Holdings' Receivables (Quarter) stood at $34.3 million in 2023, then surged by 35.66% to $46.6 million in 2024, then decreased by 12.35% to $40.8 million in 2025.
  • Its last three reported values are $40.8 million in Q2 2025, $46.6 million for Q4 2024, and -$4.1 million during Q2 2024.